XML 37 R25.htm IDEA: XBRL DOCUMENT v3.26.1
Collaboration Agreements (Details) - USD ($)
3 Months Ended 6 Months Ended
Jan. 30, 2026
May 31, 2022
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Feb. 28, 2026
Dec. 31, 2025
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Contract liabilities, noncurrent     $ 1,830,000   $ 1,830,000     $ 18,669,000
Contract liabilities               $ 18,700,000
Revenue     0 $ 0 36,839,000 $ 0    
Collaborative Arrangements | Newsoara Biopharma Co Ltd                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
License fee received $ 20,000,000.0           $ 20,000,000.0  
Collaboration revenue recognized 50,000,000.0              
Potential development and regulatory milestone payments receivable $ 65,000,000.0   3,000,000.0   3,000,000.0      
G42 Investments                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Shares sold (in shares)   259,657            
Aggregate gross purchase price   $ 12,500,000            
G42 Investments | G42 Agreements                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Sale of stock, consideration received on transaction, gross   25,000,000.0            
Accounts and financing receivable, after allowance for credit loss, current   12,500,000            
Contingent consideration transferred, aggregate share value   30,000,000.0            
Contingent consideration transferred, cash   $ 30,000,000.0            
Contract liabilities, noncurrent     18,700,000   18,700,000      
Note receivable, discount paid         600,000      
Contract liabilities     1,300,000   1,300,000      
Revenue from collaborative arrangement     0 0 0 0    
Cogna | G42 Agreements                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Collaborative arrangement, royalties receivable, period   10 years            
Cogna | Collaborative Arrangements | IP License                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Revenue     0 0 16,900,000 0    
Cogna | Commercial Supply Agreement                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                
Contract liabilities     500,000   500,000      
Revenue     $ 0 $ 0 $ 0 $ 0